-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the spread and clustering of the new crown pneumonia epidemic in many places across the country have increased, causing social concern
.
According to data from Minai.
com, in 2021, the sales scale of throat proprietary Chinese medicines in China's three major terminal markets (see the end of this article for statistical scope) exceeded 9.
5 billion yuan.
Among them, the in-hospital market continues to warm up, and the concentration is high, the total market share of TOP20 products exceeds 90%, 11 products have sold more than 100 million, and 15 exclusive varieties such as Yangtze River and Lei Yunshang "Baping"
.
The sales scale exceeded 9.
5 billion yuan
The market for proprietary Chinese medicines in the throat has warmed up
Throat proprietary Chinese medicine is widely used in dry throat soreness, acute and chronic laryngitis, tonsillitis, pharyngitis (herpes), epiglottitis and other diseases caused by upper respiratory tract infection, and the related drug market continues to expand
.
According to data from Minai.
com, in recent years, the scale of the throat proprietary Chinese medicine market in China's three major terminal markets has increased year by year, and in 2020, affected by the epidemic, the sales scale has declined, and the throat proprietary Chinese medicine market has warmed up, with a year-on-year increase of about 4%.
。
Sales of proprietary Chinese medicines in China's three major terminal markets in recent years (RMB 10,000)
Throat proprietary Chinese medicines are basically "evenly divided" in the in-hospital market (public hospitals + public primary medical care) and out-of-hospital markets (physical pharmacies + online pharmacies), of which the in-hospital market continues to warm up, with a year-on-year increase of 2.
16% in 2021 and a year-on-year increase of 1.
76%
in the first half of 2022 。
TOP20 product exposure
Lei Yunshang, Beilin Pharmaceutical.
.
.
Exclusive variety list
In recent years, the total market share of the top 20 proprietary Chinese medicine products in China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as Chinese public medical institutions) has exceeded 90%.
。
Top 20 products of terminal throat proprietary Chinese medicine in China's public medical institutions in 2021
Note: Non-exclusive, non-medical insurance varieties - representative
In terms of sales, 11 of the top 20 proprietary Chinese medicine products in 2021 had sales of more than 100 million yuan; From the perspective of growth rate, 16 of the 20 proprietary Chinese medicines showed positive growth, and 5 products increased by more than 50%, of which the sales growth rate of Liushen capsules exceeded 170%.
From the perspective of enterprises, the exclusive variety "Baping" in the Top20, 15 of the 20 proprietary Chinese medicines are exclusive varieties (including exclusive dosage forms), involving 11 pharmaceutical companies, Xi'an Beilin Pharmaceutical, Lei Yunshang Pharmaceutical, Hunan Times Sunshine Pharmaceutical have a number of exclusive varieties listed.
Xi'an Beilin Pharmaceutical has 3 varieties on the list, of which the annual sales of golden throat loose knot capsules exceed 100 million; Lei Yunshang Pharmaceutical has 2 varieties on the list, Liushen Pill ranks third, and the sales growth rate of Liushen capsules exceeds 170%; Hunan Times Sunshine Pharmaceutical also has 2 varieties on the list, and the sales volume exceeds 100 million yuan
.
Source: Minainet database, company official website, etc
Note: Minai.
com's "Drug Competition Pattern of China's Three Major Terminal and 6 Major Markets", the statistical scope is: urban public hospitals and county-level public hospitals, urban community centers and township health centers, urban physical pharmacies and online pharmacies, excluding private hospitals, private clinics, village clinics, excluding county and rural pharmacies; The above sales are calculated
based on the average retail price of the product at the terminal.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
